Modern Veterinary Therapeutics
- Company typePrivate
- Founded1996
- HeadquartersSunrise, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Modern Veterinary Therapeutics firmographics
Firmographics- Name
- Modern Veterinary Therapeutics
- Legal name
- Modern Veterinary Therapeutics
- Website
- https://modernveterinarytherapeutics.com
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Modern Veterinary Therapeutics industry classification
Industry- Product category
- Veterinary Pharmaceuticals
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology) (HLAMAIAH)
- akta.pro secondary industries
- Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB), Biologics & Immunotherapies (Non-vaccine) (HLAMAEAK)
Keywords
Where Modern Veterinary Therapeutics is headquartered
LocationHeadquarters
- HQ city
- Sunrise
- HQ country
- United States
- HQ region
- North America
Markets served
Modern Veterinary Therapeutics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- Veterinary Pharmaceutical Products: Sale of trusted pharmaceuticals, biologics, and diagnostics to licensed veterinarians. Products include anti-inflammatory agents, sedatives, antibiotics, antiparasitics, and diagnostic test kits for various animal species.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Veterinary pharmaceutical products sold to licensed veterinarians |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Modern Veterinary Therapeutics product offering
Product offeringCore offering
Modern Veterinary Therapeutics develops, markets, and distributes a specialized portfolio of veterinary pharmaceuticals (anti-inflammatory agents, sedatives, analgesics, antibiotics, parasiticides, antifungals, reproductive hormones, bronchodilators), biologics (immunomodulators), and diagnostic test kits (canine heartworm and parvovirus antigen tests). Products are categorized by target species — cattle, horses, swine, sheep, cats, dogs, and ferrets — and are sold exclusively to licensed veterinarians through a credential-gated B2B website supported by dedicated sales representatives.
Product overview
Modern Veterinary Therapeutics offers a specialized product portfolio of trusted pharmaceuticals, biologics, and diagnostics for veterinarians. The portfolio includes anti-inflammatory medications (Ketoprofen V, Flutrexin), antibiotics (Enrotron 50, Tulinovet, Hymatil, Respotil), sedatives and analgesics (Cepetor, Dexvetidine, Xylased, Revertor), reproductive management products (Cloprostenol Veyx, Gonavet, Maprelin), diagnostic test kits (Canine Heartworm Antigen Test, Canine Parvovirus Antigen Test), topical parasiticides (Selavectine, Moxicloprid), and specialty products for specific species. Products are categorized by target species including cattle, horses, swine, sheep, cats, dogs, and ferrets. The company sells directly to licensed veterinarians through a specialized B2B platform.
Differentiator
Problem solved
Functional benefit
Products and services
- Imaverol (Enilconazole) Antifungal treatment for veterinary use, re-introduced following customer demand. Sold to licensed veterinarians.
- Flutrexin (Flunixin) Anti-inflammatory analgesic medication for veterinary use, newly launched. Sold to licensed veterinarians.
- Bovicam 20 (Meloxicam) Anti-inflammatory medication for cattle. Sold to licensed veterinarians.
- Cepesedan (Detomidine Hydrochloride) Sedative and analgesic for veterinary use. Sold to licensed veterinarians.
- Cepetor (Medetomidine Hydrochloride) Sedative and analgesic medication for animals. Sold to licensed veterinarians.
- Cloprostenol Veyx (Cloprostenol) Prostaglandin analog for reproductive management in livestock. Sold to licensed veterinarians.
- Cloprostenol Veyx SW (Cloprostenol) Prostaglandin analog for reproductive management in swine. Sold to licensed veterinarians.
- Detomequin (Detomidine Hydrochloride) Sedative and analgesic combination product. Sold to licensed veterinarians.
- Dexvetidine (Dexmedetomidine Hydrochloride) Sedative and analgesic medication. Sold to licensed veterinarians.
- Enrotron 50 (Enrofloxacin) Antibiotic for veterinary use. Sold to licensed veterinarians.
- EquiNAC (N-Acetyl-L-cysteine) Mucolytic agent for respiratory conditions. Sold to licensed veterinarians.
- Fatroseal (Bismuth Subnitrate) Gastrointestinal protectant for livestock. Sold to licensed veterinarians.
- Gonavet (Gonadorelin [6-D-Phe]) Gonadotropin-releasing hormone analog for reproductive management. Sold to licensed veterinarians.
- Hymatil (Tilmicosin) Antibiotic for livestock respiratory infections. Sold to licensed veterinarians.
- Ketoprofen V (Ketoprofen) Anti-inflammatory medication for cattle, horses, and swine. Sold to licensed veterinarians. Marked its 10-year anniversary in September 2025.
- Maprelin XP-10 (Peforelin) Gonadotropin-releasing hormone analog for reproductive management. Sold to licensed veterinarians.
- Moxicloprid (Imidacloprid and Moxidectin Topical Solution) Topical parasiticide for internal and external parasites. Sold to licensed veterinarians.
- Placadine (Medetomidine Hydrochloride) Sedative and analgesic medication. Sold to licensed veterinarians.
- Pulmo-Clear (Caprine Serum Fraction, Immunomodulator) Immunomodulator biologic for respiratory support in goats. Sold to licensed veterinarians.
- Respipulmin (Clenbuterol Hydrochloride Syrup) Bronchodilator syrup for respiratory conditions. Sold to licensed veterinarians.
- Respotil (Tilmicosin Oral Concentrate) Antibiotic oral concentrate for respiratory infections. Sold to licensed veterinarians.
- Revertidine (Atipamezole Hydrochloride) Sedative reversal agent. Sold to licensed veterinarians.
- Revertor (Atipamezole Hydrochloride) Sedative reversal agent. Sold to licensed veterinarians.
- Selavectine (Selamectin Topical Solution) Topical parasiticide for internal and external parasites. Sold to licensed veterinarians.
- Tulinovet (Tulathromycin) Antibiotic for livestock respiratory infections. Sold to licensed veterinarians.
- Xylased 20 (Xylazine) Sedative and muscle relaxant for veterinary use. Sold to licensed veterinarians.
- Xylased 100 (Xylazine) Sedative and muscle relaxant for veterinary use at higher concentration. Sold to licensed veterinarians.
- Canine Heartworm Antigen Test Kit Antigen test kit for detecting heartworm in dogs. Sold to licensed veterinarians.
- Canine Parvovirus Antigen Test Kit Antigen test kit for detecting canine parvovirus. Sold to licensed veterinarians.
- Canine Parvovirus-Coronavirus Antigen Test Kit Antigen test kit for detecting both canine parvovirus and coronavirus. Sold to licensed veterinarians.
- One-Step Heartworm Antigen Test Kit Rapid antigen test for heartworm detection. Sold to licensed veterinarians.
Companies that use Modern Veterinary Therapeutics
Customer profileSegments3 records
Ideal customer profiles1 record
Modern Veterinary Therapeutics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Modern Veterinary Therapeutics partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights3 records
Modern Veterinary Therapeutics competitors and assessment
Company assessmentEmerging players
- Animalcare Group: UK-listed smaller veterinary pharmaceutical company with companion animal and livestock products including anti-infectives and parasiticides — comparable in scale and product mix to Modern Veterinary Therapeutics.
Direct peers
- Bimeda: Global veterinary pharmaceutical and biological products company with a multi-species portfolio of anti-infectives, anti-inflammatories, and reproductive products — closely comparable product breadth to Modern Veterinary Therapeutics.
- Dechra Pharmaceuticals: Specialty veterinary pharmaceuticals company focused on therapeutics for companion animals and livestock, with a portfolio including anti-inflammatories, sedatives, and reproductive products — directly comparable product categories to Modern Veterinary Therapeutics.
- Norbrook Laboratories: Privately-held veterinary pharmaceutical manufacturer with anti-infectives, anti-inflammatories, and parasiticides for both companion animals and livestock — similar product categories and private-company profile to Modern Veterinary Therapeutics.
- Ceva Santé Animale: Global veterinary pharmaceutical and biological products company with comparable portfolio breadth across companion animals and livestock, including reproductive and respiratory therapeutics similar to Modern Veterinary Therapeutics' offerings.
- Virbac: Global veterinary pharmaceutical company with a strong portfolio in companion animal and livestock therapeutics, including anti-inflammatories, parasiticides, and reproductive products — overlapping categories with Modern Veterinary Therapeutics.
- Vetoquinol: Global specialty veterinary pharmaceutical company with a similar focus on therapeutic products for companion animals and livestock (anti-inflammatories, antibiotics, reproductive). Closest direct comparable in scale and product mix to Modern Veterinary Therapeutics.
Broad incumbents
- Zoetis: World's largest animal health company with broad portfolio in companion animal diagnostics, parasiticides, anti-infectives, and livestock therapeutics — the dominant industry incumbent against which Modern Veterinary Therapeutics competes for shelf space and veterinarian mindshare.
- Elanco Animal Health: One of the largest global animal health companies with overlapping portfolio in companion animal parasiticides (Imidacloprid/moxidectin), anti-infectives, and livestock therapeutics — much larger scale but a key competitive benchmark.
- Phibro Animal Health: Larger publicly-traded animal health and nutrition company with portfolio overlap in livestock antibiotics (Tilmicosin), anti-inflammatories, and reproductive products — broader portfolio but directly comparable therapeutic categories.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Modern Veterinary Therapeutics social profiles
Digital presenceModern Veterinary Therapeutics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Modern Veterinary Therapeutics leadership team
Management profileNumber of profiles
Modern Veterinary Therapeutics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Modern Veterinary Therapeutics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Modern Veterinary Therapeutics
What does Modern Veterinary Therapeutics do?
Modern Veterinary Therapeutics develops, markets, and distributes a specialized portfolio of veterinary pharmaceuticals (anti-inflammatory agents, sedatives, analgesics, antibiotics, parasiticides, antifungals, reproductive hormones, bronchodilators), biologics (immunomodulators), and diagnostic test kits (canine heartworm and parvovirus antigen tests). Products are categorized by target species — cattle, horses, swine, sheep, cats, dogs, and ferrets — and are sold exclusively to licensed veterinarians through a credential-gated B2B website supported by dedicated sales representatives.
Is Modern Veterinary Therapeutics a public or private company?
Modern Veterinary Therapeutics is a private company. It is classified as unknown and is currently operating.
When was Modern Veterinary Therapeutics founded?
Modern Veterinary Therapeutics was founded in 1996. It employs 11 to 50 people.
Where is Modern Veterinary Therapeutics based?
Modern Veterinary Therapeutics is headquartered in Sunrise, United States, in the North America region.
How does Modern Veterinary Therapeutics make money?
One revenue line is on record: veterinary Pharmaceutical Products.
Who are Modern Veterinary Therapeutics's main competitors?
Animalcare Group is listed as an emerging player. Direct peers are Bimeda, Dechra Pharmaceuticals, Norbrook Laboratories, Ceva Santé Animale, Virbac and Vetoquinol. Broad incumbents are Zoetis, Elanco Animal Health and Phibro Animal Health.
Does Modern Veterinary Therapeutics have an API?
No public API is recorded for Modern Veterinary Therapeutics.
What industry is Modern Veterinary Therapeutics in?
Modern Veterinary Therapeutics's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAIAH, Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology), with a secondary code of HLAMAEAB, Livestock & Production Animal Therapeutics (Rx). Its NAICS code is 325414 and its SIC code is 2834.